EPRX β€” EUPRAXIA PHARMACEUTICALS INC

Ownership history in Logos Global Management LP  Β·  1 quarter on record

This page tracks every 13F SEC filing in which Logos Global Management LP reported a position in EUPRAXIA PHARMACEUTICALS INC (EPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.48% (2025 Q3)
πŸ“Š Avg. % of fund
0.48%
πŸ“… First filed
2025 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
1
% of Fund (quarterly)    EPRX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 900,000 β€” β€” 0.48% $5.3M $5.90

🏒 Other funds also holding EPRX

As of 2025 Q4 β€” sorted by position size

Ally Bridge Group (NY) LLC 3Y 3.13% GREAT POINT PARTNERS LLC 3Y 7Y 2.94% Velan Capital Investment Management LP 3Y 1.54% Vivo Capital, LLC 3Y 7Y 0.66% Ikarian Capital, LLC 3Y 0.36% Beutel, Goodman & Co Ltd. 3Y 7Y 0.17% Affinity Asset Advisors, LLC 3Y 0.13% SummitTX Capital, L.P. 0.04% SCOTIA CAPITAL INC. 3Y 7Y 0.04% INGALLS & SNYDER LLC 3Y 7Y 0.02%
← Back to Logos Global Management LP Holdings